A lthough considerable information on murine dendritic epidermal cells (dEC) 1 expressing monomorphic TCtL-'v/g heterodimers has accumulated during the last decade (1, 2) , the physiological function of dEC remains largely speculative. Previous studies, including our own (3) (4) (5) , suggest that these 'V/~+ dEC residing in the epidermis may have originally evolved to serve as self-protection mechanism(s). The availability of mice congenitally lacking TCR-'v/~-expressing cells by gene targeting has enabled us to investigate the functional role of'v/~+ dEC in vivo: if'v/~+ dEC are indeed specialized for a self-protection mechanism tAbbreviations used in this paper: B6 mice, C57B1/6 mice; dEC, dendritic epidermal cells; ~-/-, ~+/-, ~+/+, homozygous, heterozygous, or wild type for the ~ gene disruption, respectively. in the epidermis by recognizing damaged self-antigens as suggested (5) , then it might be anticipated that mice lacking 'V/~+ T cells would develop a severe inflammatory skin disease evoked by an unregulated T cell-mediated attack on the epidermis. However, contrary to our expectation, prior studies using mice congenitally lacking 'v/g+ T cells have never documented spontaneous development of inflammatory skin diseases. This finding was not surprising when we considered the presumptive redundancy of self-protective mechanisms: under conditions of physiologic antigen stimulation, alternative self-protection mechanisms would be expected to mobilize and mask a congenital lack of'v/~+ dEC. In light of such functionally redundant pathways of self-protection mechanisms, we reasoned that 'V/8 + dECmediated self-protection mechanisms would become evi-dent only when excessive self-inflicted immune responses against the epidermis are induced in mice congenitally lacking "y/8 + T cells in such a site-restricted manner that it cannot afford to be substituted for by other subtle self-protection mechanisms.
In this regard, we have previously established a murine model of cutaneous GVHD best suited for elucidation of the potential role of',//8 + dEC as part of the self-protection mechanisms: cutaneous GVHD characterized by selective destruction of epidermal structures associated with massive T cell infiltrates can be induced in normal mice by intradermal inoculation of CD4 + autoreactive T cells into the footpad (6); this experimentally induced cutaneous GVHD was a self-limiting event, and the epidermis spontaneously recovered from the destruction becomes resistant to subsequent attempts to induce cutaneous GVHD (4); and the long-term, local resistance to cutaneous GVHD is likely to depend on the expansion of ~//B + and e~/f3 + dEC within the epidermis (4, 7). However, no direct evidence to indicate that the resistance is indeed mediated by "y/8 + dEC has been demonstrated in these studies. The use of our murine model for cutaneous GVHD and mice congenitally lacking ~/8 + T cells has provided the opportunity to delineate, in the absence of other confounding issues, the role of~//8 + dEC as the tissue-selective, self-protection mechanisms.
Materials and Methods
Mice. Mice homozygous (8 -/-) and heterozygous (8 +/-) for the 8 gene disruption on the (C57B1/6 • 129)F 1 background were generated, as described in detail previously (8) . These mice were backcrossed at least three times to C57B1/6 (B6) mice. PCR analysis of tail DNA confirmed the absence of the normal 8 gene. B10.Thy-l.1 mice were bred and maintained in our animal facilities, and B6 mice were obtained from Charles River Japan, Inc. (Atsugi, Kanagawa, Japan). These mice were maintained under pathogen-free conditions in our animal facility.
G VHD-inducing Autoreaaive T Cel& The derivation and maintenance of the cloned TCtL-~/[3 § CD4 T cell line BB5 have been described in detail previously (9) : BB5 is an autoreactive T cell clone derived from B6 mice and is specific for I-A b. BB5 is capable of migrating into the epidermis upon its intradermal inoculation into the footpads of syngeneic mice and causes the destruction of the epidermis, histologic changes identical to those seen in human cutaneous GVHD (6, 10) .
Assay for DTH Responses. As described previously (6, 10) , the autoreactive T cells were harvested from culture 7-10 d after antigenic stimulation. Before the T cells were used in experiments, dead cells in the preparation were removed on a lymphocyte separation media (Sigma Chemical Co., St. Louis, MO) density gradient. After being washed with HBSS three times, remaining cells with >97% viability were injected intradermally in a volume of 25 ~1 into hind footpads ofreceipient mice (2 X 106 cells/footpad). The resultant swelling was measured with a dial thickness gauge at several time points after injection of the T cells.
Assay for Cutaneous GVHD. The cutaneous GVHD induced by the intradermal injection of the autoreactive T cells was evaluated both semiquanfitatively by the intensity of epidermal invasion ofT cells and the severity of epidermal cell damage, as previously described (4, 6, 10) . The results were expressed as the mean number of lymphoid cells • SD per linear millimeter of epidermis that was calculated from that within the total epidermal length surveyed. The severity of the epidermal cell damage was scored according to the grading system described by Lerner et al. (11) for cutaneous GVHD.
Immunofluorescence Staining. Epidermal sheets from the footpads were stained by the two-color immunofluorescence method, as previously described (7). The following mAbs were used: FITC-labeled anti-Thy-l.1 (mouse IgG2b; Meiji Laboratories, Tokyo, Japan); FITC-labeled anti-Thy-l.2 (clone 30-H12, rat IgG2b; Becton Dickinson & Co., Mountain View, CA); PE-conjugated anti-Thy-l.2 (clone 53-2.1, rat IgG2a; PharMingen, San Diego, CA), FITC-or PE-conjugated CD3e (clone 145-2Cll, hamster IgG; PharMingen); FITC-or PE-conjugated anti-CD4 (clone 1KM4-5, rat IgG2a, k; PharMingen); FITC-or PE-conjugated anti-CD8a (clone YTS 169.4, rat IgG2b; CALTAG Laboratories, South San Francisco, CA); PE-conjugated anti-CD8b (clone 53-6.8, rat IgG1; PharMingen); FITC-or PE-conjugated anti-TC1K-ot/f3 (clone H57-597, hamster IgG; PharMingen); FITC-or PE-conjugated anti-TCR-'y/B (clone GL3, hamster IgG; PharMingen); and FITC-or PE-conjugated anti-V~/5 (clone F536, hamster IgG; PharMingen). The densities of dEC were assessed by counting 10 random fields of 0.125 mm 2 per ear or footpad specimen with the aid of an ocular grid, as described previously (4, 7).
Reconstitution of 8 -/-Mice with y/8 + dEC Precursors.
For the reconstitution of~ -/-mice with ~//8 + dEC precursors, day 14, 15, or 16 fetal thymocytes obtained from B10.Thy-l.1 wild-type mice (8 +/+) were injected ("1.2-1.5 • 10 7 cells/mouse) into the tail vein of 8 -/-mice (Thyl.2). In some experiments, these fetal thymocytes were divided into two samples. The first sample was left unfractionated, and V~5 + cells were purified from the second by positive selection by flow cytometry. Our preliminary experiments demonstrated that intravenous injection of the day 16 fetal thymocytes (unfractionated population) resulted in the appearance of donor-type Thy-l.1 + dEC in the footpad epidermis of 8 -/-mice 2 mo after cell transfer, as previously described by Payer et al. (12) .
Results and Discussion
Mice homozygous for the mutant TCR-8 gene (8 -/-) were outwardly indistinguishable from heterozygous (8 -/+) or wild-type (8 +/+) littermates on gross physical inspection. As predicted by previous work (8) using epidermal sheets prepared from ear skin of g -/-and B +/-mice, ",//g + dEC expressing identical TCR encoded by V"/5/V81 genes were completely absent from the epidermis of 8 -/-mice, and the vast majority of dEC (density of Thyl + dEC: 152 + 59/mm 2, n = 13) in 8 -/-mice were found to react with anti-CD3e (92%) and anti-TCR-o#f3 mAbs (80%); these 0#[3 + dEC occurred in ,~30% of the densities of the dEC expressing TCR-~/8 observed in the epidermis of 8 +/-(Thyl + dEC: 495 • 130/mm 2, n = 11) and 8 +/+ mice, in which ci/[~ + dEC were only sparsely populated. The morphologic appearance and distribution of a/f3 + dEC found in 8 -/-mice were different from ~//8 + dEC in 8 +/-mice: in the ear of 8 +/-mice, "//8 + dEC were diffusely distributed in a regular, dense network throughout the epidermis as well as those in 8 +/+ littermates, whereas or/f3 + dEC in 8 -/-mice were unevenly distributed in many areas; and (4). Surprisingly, as s h o w n in Table 1 and (Fig. 3) , indicating that the inability o f 8 -/ -mice to induce resistance could be due to complete deletion o f y / 8 + d E C from the epidermis. H o w e v e r , the possibility remained to be ruled out that the inability o f 8 -/ - Data are cumulative from two independent experiments. *On day -21, 2 • 106 BB5 cells were injected to induce resistance, and on day 0, 2 • 106 BB5 cells were again injected as described in Table 1 . * 8 -/-mice that had been intravenously injected with fetal thymocytes obtained from 8 +/+ B10.Thyl.1 mice 2 mo before were used for the ~//8 + dEC-reconstituted 8 -/-mice. At the time of killing, the reconstitution of 8 -/-mice with ~//8 + dEC was confirmed by immunofluorescence staining of epidermal sheets obtained from the ear, and only the data in those mice in which the reconstitution with "//8 + dEC was confirmed are given. P <0.05 compared with control mice without pretreatment on day -21. and 8 +/+ mice, the 'y/8 + dEC-reconstituted 8 -/-mice were tested for their ability to induce resistance to cutaneous GVHD. As shown in Fig. 4 B, the parallel expansion of or/[3 + dEC and fetal thymocyte-derived 'y/8 + dEC was observed in the epidermis of the 'y/8 + dEC-reconstituted 8 -/-mice that had recovered spontaneously from the first induction of GVHD; and the capacity of the mice to protect the epidermis against cutaneous GVHD was subsequently restored toward levels close to that of 8 +/-mice (Table 2) ; no significant difference was detected in the density and phenotype ofcx/B + dEC between the "resistant" epidermis of the 'y/8 + dEC-reconstituted 8 -/-mice and the "susceptible" epidermis of 8 -/-mice that had not received day 16 fetal thymocytes (973 -+ 167 vs. 985 -+ 82/mm2; n = 4). These results indicate that fetal thymocyte-derived 'y/8 + dEC expressing TCtL V'y5 are essential for resistance to the induction of cutaneous GVHD under conditions in which the epidermis is severely damaged in a site-restricted manner, although they are not absolutely required for the expansion or recruitment of or/[3 + dEC precursors into the regenerating epidermis. However, we were unable to determine conclusively whether a particular subset of "y/8 + dECbearing TCtL V'y5 could be the only cell type responsible for the resistance because, for unknown reasons, the reconstitution of 8 -/-mice with 'y/8 + dEC was possible only when unfractionated fetal thymocytes, but not the V'y5 + population purified from the former, were used. There are a number of different ways in which activated 'y/8 + dEC could mediate the site-restricted resistance to a second induction of GVHD. The most straightforward interpretation of our results might be that the resistance is directly mediated by 'y/8 + dEC that eliminate or suppress the autoreactive T cells to cause the GVHD. However, recent studies (15, 16) have suggested an immunoregulatory, rather than an effector (cytotoxic), function of'y/B + T cells that can control the activation and differentiation of0t/[3 + T cells in large numbers: this appears to be a particularly effective means of maintaining immunological homeostasis in the epidermis by relatively small numbers of'y/8 + dEC. Thus, direct lysis or suppression of the autoreactive T cells by 'y/8 + dEC may not be the mechanism responsible for the resistance in our system. Instead, we favored the second possibility that ot/[3 + dEC would also be necessary to act synergistically with 'y/8 + dEC in protecting the epidermis against the GVHD because our results demonstrate that the expansion of or/[3 + dEC was excessive relative to that of'y/8 + dEC in the "resistant" epidermis, and our previous studies with lethally irradiated bone marrow chimeras (8) showed that the expansion of adult thymus-derived Thyl + dEC expressing TCR-(x/[3 is crucial to the induction of the resistance. Consistent with this possibility, our recent preliminary studies with the use of o~/[3 T cell--deficient mice ([3 -/-) have shown that, like 8 -/-mice, significant delay in the spontaneous recovery from GVHD was observed and that, despite an expansion of y/8 + dEC, the resistance to a second induction of GVHD after spontaneous recovery was incomplete in these mice (Shiohara, T., unpublished data). An important role for activated 'y/8 + dEC in the resistance to GVHD might be to activate more numerous secondary effector cells, such as (x/[3 + dEC, via secretion of specific combinations of cytokines. Thus, our experimental model provides important paradigms to unravel the complex nature of the cross-talk among 'y/8 + dEC and or/[3 + dEC.
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